Collegium Pharmaceutical COLL
NASDAQ COLL
$22.23 -0.40 (-1.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Collegium Pharmaceutical (COLL) Current Deferred Revenue (2025 - 2026)

Updated

Collegium Pharmaceutical (COLL) recorded Current Deferred Revenue of $667,000 in Q2 2026, unchanged from the prior quarter.

Analysis

Collegium Pharmaceutical (COLL) Current Deferred Revenue (2025 - 2026) Analysis & Trends

Starting with Q3 2025, Collegium Pharmaceutical's Current Deferred Revenue history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at $667,000 (Q1 2026), $667,000 (Q4 2025) and $667,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Collegium Pharmaceutical 735.44 Mn -488.33 Mn 110.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 667,000.00
Mar 31, 2026 667,000.00
Dec 31, 2025 667,000.00
Sep 30, 2025 667,000.00
API Access

Collegium Pharmaceutical Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=COLL&period=max&api_key=YOUR_API_KEY